Diabetic emergencies Flashcards

1
Q

What is the diagnostic criteria for diabetic ketoacidosis (DKA)?

A

An emergency diabetes complication, characterised by:

  • Hyperglycaemia >11mmol/L; or known DM
    • Euglycaemic DKA can occur with SGLT-2 inhibitors
  • Acidosis: bicarb <15mmol/L and/or venous pH <7.3
  • Significant ketonuria (2+) or ketonaemia (>3mmol/L)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List five possible triggers of DKA

A
  • Infection
  • Discontinuation of insulin
  • Inadequate insulin
  • Cardiovascular disease
  • Drugs:
    • Steroids, sympathomimetics, A-blockers, B-blockers, diuretics, SGAs, SGLT2i
  • Stress: Surgery, trauma, pregnancy
  • Chemotherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the presentation of DKA

A

Initial: Polyuria; polydipsia; vomiting; dehydration; abdominal pain

Severe: Altered mental state; coma (5%)

Additional: Acetone breath (pear drop); Kussmaul breathing/tachypnoea; weight loss; weakness; lethargy

Temperature is often subnormal even in presence of infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

List three symptoms or signs of mild-moderate dehydration

A
  • Increased thirst
  • Tiredness
  • Dizziness/headache
  • Oliguria
  • Dry mucous membranes
  • Sunken eyes
  • Postural hypotension
  • Reduced skin turgor
  • Delayed capillary refill
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List five signs of severe dehydration

A
  • Weakness
  • Confusion; coma
  • Tachycardia with weak pulse
  • Hypotension
  • Anuria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How may DKA present on NEWS score?

A
  • EWS >6
  • Pulse >100 bpm or <60 bpm
  • SBP <90 mmHg
  • GCS <12 or abnormal AVPU
  • SaO2 <92%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Give five investigations in suspected DKA?

A
  • Urine dip: ketonuria (2+); glycosuria
  • ABG/VBG: pH <7.0
  • VBG: HCO3 <5mmol/L
  • Capillary and serum blood glucose
  • Blood ketones >6mmol/L or ketonuria
  • U+E: K+ <3.5mmol/L
  • ECG; MI screen
  • CXR
  • MSU; blood cultures
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Outline the immediate management of DKA

A
  • A-E assessment
  • If severe: immediate senior review; consider HDU/ITU
  • IV access and 0.9% sodium chloride infusion
    • Fluid resus if SBP <90
    • 1st litre (1h); subsequent 2L (4h); 2L (8h); 2L (12h)
  • Potassium replacement
    • >5.5: nil
    • 3.5-5.5: 20mmol/500mL
    • <3.5: senior review
  • Fixed rate IV insulin (Actrapid) [0.1 units/kg/h] ± IM/SC STAT dose
    • Hourly ketone and CBG monitoring
    • Continue any long acting insulin
    • Add 10% glucose if CBG <14mmol/L
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When is DKA considered to be resolved?

What subsequent management should occur once resolved?

A

Resolved DKA

  • Venous pH >7.3; and/or
  • Blood ketones <0.6mmol/L

Subsequent management

  • Review insulin infusion: target CBG 5-10mmol/L
  • Encourage oral intake and switch to SC insulin
    • Otherwise switch to VRII
  • Refer to specialist diabetes team
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is Hyperosmolar hyperglycaemic state (HHS)?

A

T2DM emergency characterised by:

  • Hyperglycaemia
  • Hyperosmolarity
  • Dehydration
  • Without significant ketoacidosis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

List 5 potential triggers for HHS

A

Co-morbidities: MI, infection, stroke/TIA, pancreatitis, PE, GI bleed, Cushing’s syndrome

Drugs: Metformin, thiazide diuretics, B-blockers, CCBs, dialysis, steroids, alcohol

Diabetes: Poor control, non-compliance, consumption of glucose-rich fluids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the presentation of HHS

A

Characteristic: dehydration and stupor/coma

Initial: dehydration, polyuria, polydipsia, weakness, leg cramps, visual impairment

Severe: lethargy, confusion, coma (rare)

Additional: Seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Outline the management of HHS

A
  • Rehydrate slowly with 0.9% saline over 48h
    • avoids cerebral damage
  • Replace K+ when urine output improves
  • Insulin if glucose not falling by 5 mmol/L
  • Maintain glucose 10-15 mmol/L in first 24h
    • avoid cerebral oedema (rapid reduction of osmolarity causes reversal of fluid shift)
  • Prophylactic LMWH and TED stockings
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What medication is associated with lactic acidosis in diabetes?

A

Metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When should lactic acidosis be suspected over DKA?

A

Severe metabolic acidosis with large anion gap Usually without significant hyperglycaemia or ketosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is lactic acidosis treated?

A

Rehydration Isotonic bicarbonate

17
Q

What is the DVLA guidance for diabetes mellitus?

A

All patients must be able to produce a blood glucose >5 mmol/L at least 45 minutes prior to driving

18
Q

Outline the management of hypoglycaemia

A
  • Oral sugar: 10-20g liquid or granulated
    • Gels, 100ml Coca cola, 110ml Lucozade
    • repeat after 10-15 minutes if needed
  • Long-acting start, slow absorbed carbs in post-prandial hypoglycaemia
  • 25-50ml IV 20% glucose + flush
  • Rationalise insulin therapy
19
Q

List 5 triggers of hypoglycaemia

A

Fasting hypoglycaemia:

  • Alcohol
  • Starvation
  • Known diabetics: insulin or sulfonylurea
  • Non-diabetics: exogenous drugs, pituitary insufficiency, liver failure, Addison’s disease, ZE syndrome, non-pancreatic neoplasms

Post-prandial hypoglycaemia

20
Q

Outline the management of hypoglycaemic coma

A
  • IV 20% glucose infusion
    • Flush with saline to prevent vein sclerosis
  • 1mg IM glucagon
    • community, untrained in IV access
  • Oral glucose once patient revives
  • IV dextrose in severe prolonged hypoglycaemia
21
Q

What may be the cause of DKA in T2DM?

A

Side effect of SGLT2 inhibitors (Canagliflozin, Dapagliflozin, Empagliflozin)